University of Tennessee’s Health Science Center is turning heads. Way before the pandemic, its gene research and mobile stroke unit were groundbreaking. Now we learn in addition to hoping to come up with a vaccine, Researchers will also be conducting clinical trials for a drug that can fight COVID-19.
A new potential COVID-19-fighting drug is being tested in Memphis. Researchers on the clinical trials hope the drug will help treat people with COVID-19 who do not require hospitalization and prevent infection among people who have had close contact with someone who tested positive. Regional One Health and the University of Tennessee Health Science Center… Read More
In early 2020, Memphis-based SOMAVAC Medical Solutions Inc. was off to a fast start. The startup, which has an FDA-approved, modern surgical drain pump device, hired a VP of sales, John Flynn, in January.
When Joe Prude called Rochester, New York, police to report his brother missing, he was struggling to understand why Daniel Prude had been released from the hospital hours earlier. Joe Prude described his brother’s suicidal behavior.
For Dr. Amber Thacker, going into medicine was more or less second nature. As a kid, she would buy old medical and science textbooks. She set up a lab in her closet.
The University of Tennessee Health Science Center and Regional One Health are partnering on a clinical trial program in Memphis to evaluate a drug for COVID-19 treatment. The Memphis medical college and hospital announced Thursday they will provide late-stage trials for Regeneron’s REGN-COV2, an antibody cocktail the company is investigating for possible treatment and prevention… Read More
If a COVID-19 vaccine is widely available in the nation even by next spring, it could be months — even after the start of school next fall — before it’s available for children. The good news is children so far are less affected by the virus. The bad news? If children aren’t vaccinated, they can spread the… Read More
Salvatore Mancarella, PhD, associate professor in the Department of Physiology in the College of Medicine at the University of Tennessee Health Science Center, was recently awarded $1.52 million from the National Institutes of Health (NIH) to support his investigations into the molecular-level causes of cardiac muscle deterioration. Also: BioEngineer
